Document is current

Any future updates will be listed below

Correction: Targeting and internalizing PEGylated nanodrugs to enhance the therapeutic efficacy of hematologic malignancies by anti-PEG bispecific antibody (mPEG × CD20)

Crossref DOI link: https://doi.org/10.1186/s12645-024-00280-4

Published Online: 2024-08-06

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark